Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,373.1
15.9 (0.47%)

 

  • STI Straits Times Index
    3,373.1
    15.9 (0.47%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,655.7
    0.3 (0.02%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    28,466.5
    95.2 (0.34%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    2,899.9
    13.0 (0.45%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    21,620.9
    204.1 (0.95%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    6,403.8
    -29.7 (-0.46%)
    Index delayed 10 minutes
  • KOR KOSPI
    2,101.4
    8.1 (0.39%)
    Index delayed 20 minutes
  • XAO XAO
    6,812.5
    31.3 (0.46%)
     

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 1,090.1M
  • Value: 895.3M
  • Rise: 221
  • Fall: 157
  • Unch: 460

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Sinwa0.047+0.016
DISA0.002-
Accrelist0.004+0.002
Singapore-eDev0.051+0.015
Jadason^0.045+0.005
Sino Grandness0.051+0.001
SingTel3.520-
Sen Yue0.039-
Genting Sing0.935+0.010
Tritech0.029-

World Indices

World Indices
Name Last Change
Nasdaq 8,204.1 +57.6
HSI 28,466.5
HSCEI 10,809.9
Jakarta 6,403.8
Nikkei 225 21,620.9
SSE Comp 2,899.9
Shanghai A 3,037.4
Shanghai B 287.4
ShenZhen A 1,616.6
ShenZhen B 967.4
PSE Comp 0.0
KOSPI 2,101.4

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

AMGEN-T AMGEN-T
Quotes 15 Minutes Delayed. Updated at 23 Jul 2019 09:00
Last (HKD): 1,000.000 Change: - High: 1,000.000 Remarks: -
Change (%): - Low: 1,000.000
Open 1,000.000 Yesterday's Close 1000.000
Buy Price 500.000 Sell Price -
Buy Volume ('000) 0.31 Sell Volume ('000) -
Cumulative Volume ('000) - Cumulative Value -
Click to show Stock Prices chart

Key Statistics

EPS (HKD) a 107.86108 Trailing EPS (HKD) e 103.82630 NAV (HKD) b 139.4091
PE a 9.271 Trailing PE f 9.631 Price / NAV b 7.1731
Dividend (HKD) d 42.716379 Cash In Hand (HKD) g 94.6983 Issued & Paid-up Shares c 609,936,000
Dividend Yield (%) d 4.272 Price / Cash In Hand g 10.560 Treasury Shares h -
Beta - 75 Daysi - R-Squared - 75 Days(%)i - Market Cap (M) 609,936.000
Beta - 500 Daysi 0.247 R-Squared - 500 Days (%)i 0.20 Enterprise Value (M) 666,541.990
Piotroski F Score 8 Exchange Code 4332 Par Value ( USD ) 0.00010
52 Weeks Volatility (%) - 6-Month VWAP n.a. Free Float (%) 99.8
Sector & Industry Health Technology - Biotechnology
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 02 May 2019.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 17 Sep 2015.
  9. Beta and R-Squared are calculated in relation to the market index using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference AMGEN-T HKEx 609,936.000 9.271 9.631 7.1731 4.272
Industry Biotechnology HKEx 49,831.600 13.259 13.859 5.6458 2.727
Local Peer SINO BIOPHARM HKEx 117,659.160 10.981 11.271 3.3944 0.782
Local Peer WUXI BIO HKEx 101,673.440 136.127 136.126 11.1536 -
Local Peer BEIGENE HKEx 59,869.452 - - 4.7407 -
Local Peer GENSCRIPT BIO HKEx 33,253.760 199.978 199.985 8.8734 -
Local Peer 3SBIO HKEx 32,796.835 21.680 21.680 3.3386 -
Local Peer HAOHAI BIOTEC HKEx 7,274.059 14.815 14.815 1.7662 -
Local Peer FRONTAGE HKEx 6,866.129 77.940 77.934 20.0940 -
Local Peer VIVA BIOTECH HKEx 6,687.994 62.360 62.358 23.3296 -
Local Peer ASCLETIS-B HKEx 6,219.829 - - 1.5914 -
Local Peer CKLIFE SCIENCES HKEx 4,132.760 15.716 15.714 0.9693 2.326
Local Peer ESSEX BIO-TECH HKEx 3,930.100 17.006 17.007 4.2308 -
Local Peer LEE'S PHARM HKEx 3,020.776 7.222 7.222 1.3665 2.313
Other Local Peers BBI LIFE SCI (HKEx), UNI-BIO GROUP (HKEx), CT ENTERPRISE (HKEx), REGENT PACIFIC (HKEx), EXTRAWELL PHAR (HKEx), BIOSINO BIO-TEC (HKEx), HAO WEN HLDGS (HKEx)
Global Peer AMGEN INC NASDAQ 107,281.643 12.781 13.286 9.9042 3.099
Global Peer GILEAD SCIENCES INC NASDAQ 82,536.960 15.131 14.008 3.7601 3.541
Global Peer CSL ASX 101,018.277 45.273 41.466 14.6569 1.022
Global Peer CELGENE CORP NASDAQ 63,099.612 15.596 13.298 7.7281 -
Global Peer BIOGEN INC NASDAQ 45,076.245 10.174 9.659 3.2593 -
Global Peer VERTEX PHARMACEUTICAL NASDAQ 44,585.544 21.268 20.691 9.4395 -
Global Peer ILLUMINA INC NASDAQ 43,847.160 53.084 51.524 11.0031 -
Global Peer REGENERON PHARMACEUTICALS INC NASDAQ 32,509.964 13.300 13.392 3.4421 -
Global Peer ALEXION PHARMACEUTICAL INC NASDAQ 27,428.670 353.465 65.871 2.8258 -
Global Peer AGILENT TECHNOLOGIES INC NYSE 21,831.956 69.089 19.545 4.2599 0.868
Other Global Peers INCYTE CORPORATION (NASDAQ), EXACT SCIENCES CORP (NASDAQ), BIOMARIN PHARMACEUTICAL (NASDAQ), SEATTLE GENETICS INC (NASDAQ), SAREPTA THERAPEUTICS INC (NASDAQ), ARRAY BIOPHARMA INC (NASDAQ), GALAPAGOS NV SPON ADR REPR 1 ORD SHS (NASDAQ), IONIS PHARMACEUTICALS INC (NASDAQ), ALNYLAM PHARMACEUTICALS INC (NASDAQ), NEUROCRINE BIOSCIENCES INC (NASDAQ), BIO-TECHNE CORP (NASDAQ), BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS (NASDAQ), BLUEBIRD BIO INC (NASDAQ), EXELIXIS INC (NASDAQ), NEKTAR THERAPEUTICS (NASDAQ), ASCENDIS PHARMA A/S SPON ADR EACH REP 1 ORD SHS (NASDAQ), BLUEPRINT MEDICINES CORP (NASDAQ), MODERNA INC (NASDAQ), Lonza (SGX), REPLIGEN CORP (NASDAQ), FIBROGEN INC (NASDAQ), TILRAY INC (NASDAQ), MIRATI THERAPEUTICS INC (NASDAQ), ACADIA PHARMACEUTICALS INC (NASDAQ), SPARK THERAPEUTICS INC (NASDAQ), CHINA BIOLOGIC PRODUCTS HLDGS INC (NASDAQ), ULTRAGENYX PHARMACEUTICAL INC (NASDAQ), ALKERMES PLC (NASDAQ), MORPHOSYS SPON ADS EACH REP 0.25 ORD SHS (NASDAQ), ALLOGENE THERAPEUTICS INC (NASDAQ), GLOBAL BLOOD THERAPEUTICS INC (NASDAQ), AMICUS THERAPEUTICS INC (NASDAQ), IOVANCE BIOTHERAPEUTICS INC (NASDAQ), ARENA PHARMACEUTICALS INC (NASDAQ), IMMUNOMEDICS INC (NASDAQ), ARROWHEAD PHARMACEUTICALS INC (NASDAQ), AGIOS PHARMACEUTICALS INC (NASDAQ), UNIQURE N.V. (NASDAQ), CRISPR THERAPEUTICS AG (NASDAQ), PTC THERAPEUTICS INC (NASDAQ), XENCOR INC (NASDAQ), ZAI LAB LIMITED ADS EACH REP 1 ORD SHS (NASDAQ), HALOZYME THERAPEUTICS INC (NASDAQ), ACCELERON PHARMA (NASDAQ), EMERGENT BIOSOLUTIONS INC (NYSE), LIGAND PHARMACEUTICAL INC (NASDAQ), GENOMIC HEALTH INC (NASDAQ), MYRIAD GENETICS INC (NASDAQ), DENALI THERAPEUTICS INC (NASDAQ), INSMED INC (NASDAQ), REGENXBIO INC (NASDAQ), NATERA INC (NASDAQ), AUDENTES THERAPEUTICS INC (NASDAQ), ENANTA PHARMACEUTICALS INC (NASDAQ), VERACYTE INC (NASDAQ), ANAPTYSBIO INC (NASDAQ), FATE THERAPEUTICS (NASDAQ), HERON THERAPEUTICS INC (NASDAQ), SANGAMO THERAPEUTICS INC (NASDAQ), EIDOS THERAPEUTICS INC (NASDAQ), ALECTOR INC (NASDAQ), OPKO HEALTH INC (NASDAQ), EDITAS MEDICINE INC (NASDAQ), INTREXON CORP (NASDAQ), EPIZYME INC (NASDAQ), COHERUS BIOSCIENCES INC (NASDAQ), RUBIUS THERAPEUTICS INC (NASDAQ), ESPERION THERAPEUTICS INC (NASDAQ), AIMMUNE THERAPEUTICS INC (NASDAQ), CORTEXYME INC (NASDAQ), NANOSTRING TECHNOLOGIES INC (NASDAQ), DICERNA PHARMACEUTICALS INC. (NASDAQ), TWIST BIOSCIENCE CORPORATION (NASDAQ), CARA THERAPEUTICS INC (NASDAQ), RADIUS HEALTH INC (NASDAQ), HOMOLOGY MEDICINES INC (NASDAQ), MOMENTA PHARMACEUTICALS INC (NASDAQ), VOYAGER THERAPEUTICS INC (NASDAQ), ZIOPHARM ONCOLOGY INC (NASDAQ), ADVERUM BIOTECHNOLOGIES INC (NASDAQ), MEIRAGTX HOLDINGS PLC (NASDAQ), LUMINEX CORP(DEL) (NASDAQ), RETROPHIN INC (NASDAQ), NGM BIOPHARMACEUTICALS INC (NASDAQ), ALDER BIOPHARMACEUTICALS INC (NASDAQ), KURA ONCOLOGY INC (NASDAQ), DECIPHERA PHARMACEUTICALS INC (NASDAQ), PACIFIC BIOSCIENCES CALIFORNIA INC (NASDAQ), INTELLIA THERAPEUTICS INC (NASDAQ), ARVINAS INC (NASDAQ), SPECTRUM PHARMACEUTICALS INC (NASDAQ), WAVE LIFE SCIENCES LTD (NASDAQ), POLYNOVO LIMITED (ASX), MYOVANT SCIENCES LTD (NYSE), STOKE THERAPEUTICS INC (NASDAQ), ZEALAND PHARMA AS SPON ADR EACH REP 1 ORD SHS (NASDAQ), RHYTHM PHARMACEUTICALS INC (NASDAQ), OMEROS CORP (NASDAQ), DBV TECHNOLOGIES SPON ADR EACH REPR 0.5 ORD (NASDAQ), MACROGENICS INC (NASDAQ), GENFIT SPON ADS EACH REP 1 ORD SHS (NASDAQ), PRECISION BIOSCIENCES INC (NASDAQ), AVROBIO INC (NASDAQ), ATARA BIOTHERAPEUTICS INC (NASDAQ), PERSONALIS INC (NASDAQ), TG THERAPEUTICS INC (NASDAQ), CYTOKINETICS INC (NASDAQ), INTRA-CELLUAR THERAPIES INC (NASDAQ), VANDA PHARMACE INC (NASDAQ), CELLECTIS ADS EACH REPR 1 ORD SPON (NASDAQ), AUTOLUS THERAPEUTICS PLC SPON ADS EA REP 1 ORD SHS (NASDAQ), UROGEN PHARMA LTD (NASDAQ), ROCKET PHARMACEUTICALS INC (NASDAQ), VIKING THERAPEUTICS INC (NASDAQ), CLOVIS ONCOLOGY INC (NASDAQ), MORPHIC HOLDING INC (NASDAQ), LEXICON PHARMACEUTICALS INC (NASDAQ), STEMLINE THERAPEUTICS INC (NASDAQ), AVITA MEDICAL LTD (ASX), KODIAK SCIENCES INC (NASDAQ), SYNTHORX INC (NASDAQ), MESOBLAST LTD SPON ADR EACH REP 5 SHS (NASDAQ), MESOBLAST LTD (ASX), NEPTUNE WELLNESS SOLUTIONS INC (NASDAQ), KARYOPHARM THERAPEUTICS INC (NASDAQ), MAGENTA THERAPEUTICS INC (NASDAQ), CYTOMX THERAPEUTICS INC (NASDAQ), MERIDIAN BIOSCIENCE INC COM (NASDAQ), TRANSLATE BIO INC (NASDAQ), AURINIA PHARMACEUTICALS INC (NASDAQ), NEXT SCIENCE LTD (ASX), CHEMOCENTRYX INC (NASDAQ), DERMIRA INC (NASDAQ), CYMABAY THERAPEUTICS INC (NASDAQ), AKEBIA THERAPEUTICS INC (NASDAQ), PROGENICS PHARMACEUTICALS INC (NASDAQ), NEXTCURE INC (NASDAQ), GLYCOMIMETICS INC (NASDAQ), PREVAIL THERAPEUTICS INC (NASDAQ), MEDICINOVA INC (NASDAQ), RIGEL PHARMACEUTICALS INC (NASDAQ), FLEXION THERAPEUTICS INC (NASDAQ), RESTORBIO INC (NASDAQ), CORBUS PHARMACEUTICALS HOLDINGS IN (NASDAQ), PROTHENA CORP PLC (NASDAQ), REPLIMUNE GROUP INC (NASDAQ), PUMA BIOTECHNOLOGY INC (NASDAQ), ACHILLION PHARMACEUTICALS INC (NASDAQ), ADAPTIMMUNE THERAPEUTICS PLC ADS EACH REPR 6 SHS (SPONS) (NASDAQ), STEALTH BIOTHERAPEUTICS CORP SPON ADS EACH REP 12 ORD SHS (NASDAQ), SCHOLAR ROCK HOLDING CORPORATION (NASDAQ), ARCUS BIOSCIENCES INC (NYSE), BIOCRYST PHARMACEUTICALS INC (NASDAQ), PDL BIOPHARMA INC (NASDAQ), HARPOON THERAPEUTICS INC (NASDAQ), NUCANA PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), MERUS B V (NASDAQ), AVID BIOSERVICES INC (NASDAQ), STARPHARMA HOLDINGS LIMITED (ASX), IMMUNOGEN INC (NASDAQ), BIOFRONTERA AG SPON ADS EACH REP TWO ORD SHS (NASDAQ), PROQR THERAPEUTICS N V (NASDAQ), KADMON HLDGS INC (NYSE), AGENUS INC (NASDAQ), UNITY BIOTECHNOLOGY INC (NASDAQ), SYROS PHARMACEUTICALS INC (NASDAQ), ELOXX PHARMACEUTICALS INC (NASDAQ), ACORDA THERAPEUTICS INC (NASDAQ), SORRENTO THERAPEUTICS INC (NASDAQ), PROTAGONIST THERAPEUTICS INC (NASDAQ), CASI PHARMACEUTICALS INC (NASDAQ), XBIOTECH INC (NASDAQ), MOLECULAR TEMPLATES INC (NASDAQ), CELLULAR BIOMEDICINE GROUP INC (NASDAQ), EIGER BIOPHARMACEUTICALS INC (NASDAQ), XENON PHARMACEUTICALS INC (NASDAQ), NEUROINSIGHTS NEUROTECH (NASDAQ), CONCERT PHARMACEUTICALS INC (NASDAQ), TELIX PHARMACEUTIC (ASX), SYNDAX PHARMACEUTICALS INC (NASDAQ), KAMADA (NASDAQ), REDHILL BIOPHARMA LTD SPON ADS EA REPR 10 ORD ILS0.00 (NASDAQ), EVOFEM BIOSCIENCES INC (NASDAQ), LA JOLLA PHARMACEUTICAL CO (NASDAQ), PIERIS PHARMACEUTICALS INC (NASDAQ), DPHARMA (Bursa), CALITHERA BIOSCIENCES INC (NASDAQ), ADMA BIOLOGICS INC (NASDAQ), GALECTIN THERAPEUTICS INC (NASDAQ), RECRO PHARMA INC (NASDAQ), DYNAVAX TECHNOLOGIES CORP (NASDAQ), GERON CORP (NASDAQ), ATHERSYS INC (NASDAQ), SYNLOGIC INC (NASDAQ), SERES THERAPEUTICS (NASDAQ), COMPUGEN (NASDAQ), FIVE PRIME THERAPEUTICS (NASDAQ), MANNKIND CORPORATION (NASDAQ), CHIASMA INC (NASDAQ), 22ND CENTURY GROUP INC (NYSE American), MERSANA THERAPEUTICS INC (NASDAQ), CHIMERIX INC (NASDAQ), AFFIMED N V (NASDAQ), NABRIVA THERAPEUTICS PLC (NASDAQ), STANDARD DIVERSIFIED INC (NYSE American), ENZO BIOCHEM INC (NYSE), XOMA CORP (NASDAQ), AXCELLA HEALTH INC (NASDAQ), TAIWAN LIPOSOME COMPANY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), BIOXCEL THERAPEUTICS INC (NASDAQ), SOLID BIOSCIENCES INC (NASDAQ), X4 PHARMACEUTICALS INC (NASDAQ), APPLIED THERAPEUTICS INC (NASDAQ), BICYCLE THERAPEUTICS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), APTOSE BIOSCIENCES INC (NASDAQ), AXOVANT GENE THERAPIES LTD (NASDAQ), ARDELYX INC (NASDAQ), PALATIN TECHNOLOGIES INC (NYSE American), CUE BIOPHARMA INC (NASDAQ), ALDEYRA THERAPEUTICS (NASDAQ), STRONGBRIDGE BIOPHARMA PLC (NASDAQ), PFENEX INC (NYSE American), JOUNCE THERAPEUTICS INC (NASDAQ), DYADIC INTERNATIONAL INC (NASDAQ), ANAVEX LIFE SCIENCES CORPORATION (NASDAQ), IMV INC (NASDAQ), TOCAGEN INC (NASDAQ), CYNATA THERAPEUTICS LTD (ASX), BIOTIME INC (NYSE American), NANTKWEST INC (NASDAQ), SESEN BIO INC (NASDAQ), KEZAR LIFE SCIENCES INC (NASDAQ), AVEO PHARMACEUTICALS INC (NASDAQ), PARATEK PHARMACEUTICALS INC (NASDAQ), ERYTECH PHARMA SPON ADR EACH REPR 1 ORD (NASDAQ), NOVAVAX INC (NASDAQ), ARBUTUS BIOPHARMA CORP (NASDAQ), INMUNE BIO INC (NASDAQ), ADURO BIOTECH INC (NASDAQ), TIZIANA LIFE SCIENCES PLC SPON ADS EACH REPR 10 ORD SHS (NASDAQ), VERASTEM INC (NASDAQ), ASLAN PHARMACEUTICALS LIMITED ADS EACH REP 5 ORD SHS (NASDAQ), NEON THERAPEUTICS INC (NASDAQ), NEUREN PHARMACEUTICALS LTD (ASX), CATALYST BIOSCIENCES INC (NASDAQ), ITERUM THERAPEUTICS PLC (NASDAQ), INFINITY PHARMACEUTICALS INC (NASDAQ), EQUILLIUM INC (NASDAQ), NAVIDEA BIOPHARMACEUTICALS INC (NYSE American), HEMISPHERX BIOPHARMA INC (NYSE American), SAVARA INC (NASDAQ), PLURISTEM THERAPEUTICS INC (NASDAQ), TREVENA INC (NASDAQ), PORT (SET), GENOCEA BIOSCIENCES INC (NASDAQ), CHAMPIONS ONCOLOGY INC (NASDAQ), FORTRESS BIOTECH INC (NASDAQ), ALPINE IMMUNE SCIENCES INC (NASDAQ), ENTASIS THERAPEUTICS HLDGS INC (NASDAQ), SUNESIS PHARMACEUTICALS INC (NASDAQ), CURIS INC (NASDAQ), CATABASIS PHARMACEUTICALS INC (NASDAQ), VBI VACCINES INC CDA (NASDAQ), FENNEC PHARMACEUTICALS INC (NASDAQ), EDAP TMS S.A. SPON ADS EACH REPR 1 ORD SHARE (NASDAQ), OTONOMY INC (NASDAQ), INFLARX N V (NASDAQ), VERMILLION INC (NASDAQ), VTV THERAPEUTICS INC (NASDAQ), HARVARD BIOSCIENCE INC (NASDAQ), UNUM THERAPEUTICS INC (NASDAQ), RESAPP HEALTH LIMITED (ASX), SELECTA BIOSCIENCES INC (NASDAQ), SURFACE ONCOLOGY INC (NASDAQ), T2 BIOSYSTEMS INC (NASDAQ), IDERA PHARMACEUTICALS INC (NASDAQ), APPLIED GENETIC TECHNOLOGIES CORP (NASDAQ), BELLICUM PHARMACEUTICALS (NASDAQ), AQUABOUNTY TECHNOLOGIES INC (NASDAQ), MERRIMACK PHARMACEUTICALS INC (NASDAQ), ORGENESIS INC (NASDAQ), IBIO INC (NYSE American), SYNTHETIC BIOLOGICS INC (NYSE American), MATINAS BIOPHARMA HOLDINGS INC (NYSE American), COHBAR INC (NASDAQ), OUTLOOK THERAPEUTICS INC (NASDAQ), MIRAGEN THERAPEUTICS INC (NASDAQ), NEWLINK GENETICS CORP (NASDAQ), ALIMERA SCIENCES INC (NASDAQ), CORREVIO PHARMA CORP (NASDAQ), ORGANOVO HLDGS INC (NASDAQ), ARAVIVE INC (NASDAQ), AQUINOX PHARMACEUTICALS INC (NASDAQ), CEL-SCI CORP (NYSE American), IMMUTEP LTD SPON ADR EACH REP 100 ORD SHS (NASDAQ), IMMUTEP LTD (ASX), OPIANT PHARMACEUTICALS INC (NASDAQ), VACCINEX INC (NASDAQ), IMUGENE LIMITED (ASX), VASCULAR BIOGENICS LTD (NASDAQ), IVERIC BIO INC (NASDAQ), PHYLOGICA LIMITED (ASX), ORTHOCELL LIMITED (ASX), PROTEOSTASIS THERAPEUTICS INC (NASDAQ), LEAP THERAPEUTICS INC (NASDAQ), FORWARD PHARMA AS SPON ADR EACH REP 2 ORD SHS (NASDAQ), MEREO BIOPHARMA GROUP PLC SPON ADS EACH REP 5 ORD SHS (NASDAQ), ZELDA THERAPEUTICS LTD (ASX), CIDARA THERAPEUTICS INC (NASDAQ), DIAMEDICA THERAPEUTICS INC (NASDAQ), HTG MOLECULAR DIAGNOSTICS INC (NASDAQ), INDIA GLOBALIZATION CAPITAL INC (NYSE American), INNOVATE BIOPHARMACEUTICALS INC (NASDAQ), SUMMIT THERAPEUTICS PLC ADS EACH REPR 5 ORD (NASDAQ), SEELOS THERAPEUTICS INC (NASDAQ), BIO-PATH HOLDINGS INC (NASDAQ), SIERRA ONCOLOGY INC (NASDAQ), APTEVO THERAPEUTICS INC (NASDAQ), ZAFGEN INC (NASDAQ), EVOGENE LTD (NASDAQ), BIOTRON (ASX), CONTRAFECT CORP (NASDAQ), SENESTECH INC (NASDAQ), RHINOMED LIMITED (ASX), MIDATECH PHARMA PLC SPON ADS EACH REP 20 ORD SHS(R/S) (NASDAQ), ARMATA PHARMACEUTICALS INC (NYSE American), ANCHIANO THERAPEUTICS LTD SPON ADS EACH REP 5 ORD SHS (NASDAQ), SOPHIRIS BIO INC (NASDAQ), INVEX THERAPEUTICS LTD NPV (ASX), CELLDEX THERAPEUTICS INC (NASDAQ), BIONANO GENOMICS INC (NASDAQ), AETERNA ZENTARIS INC (NASDAQ), AEVI GENOMIC MEDIC (NASDAQ), ONCOLYTICS BIOTECH INC (NASDAQ), VISTAGEN THERAPEUTICS INC (NASDAQ), MEMPHASYS LTD (ASX), ONCOSIL MEDICAL LIMITED (ASX), ORAGENICS INC (NYSE American), MICROBOT MEDICAL INC (NASDAQ), SOLIGENIX INC (NASDAQ), AZURRX BIOPHARMA INC (NASDAQ), ADALTA LTD (ASX), ISORAY INC (NYSE American), REXAHN PHARMACEUTICALS INC (NASDAQ), CELLECTAR BIOSCIENCES INC (NASDAQ), BIOCEPT INC (NASDAQ), CO DIAGNOSTICS INC (NASDAQ), HEAT BIOLOGICS INC (NASDAQ), PATRYS LIMITED (ASX), PROTEOMICS INTL LABORATORIES LTD (ASX), ACTINIUM PHARMACEUTICALS INC (NYSE American), HISTOGENICS CORP (NASDAQ), KAZIA THERAPEUTICS LIMITED (ASX), FIBROCELL SCIENCE INC (NASDAQ), NOVABAY PHARMACEUTICALS INC (NYSE American), KAZIA THERAPEUTICS LIMITED SPON ADR EACH REP 10 ORD SHS (NASDAQ), PRECIPIO INC (NASDAQ), CAPRICOR THERAPEUTICS INC (NASDAQ), ALTERITY THERAPEUTICS LIMITED (ASX), SELLAS LIFE SCIENCES GROUP INC (NASDAQ), PULMATRIX INCORPORATED (NASDAQ), CLEVELAND BIOLABS INC (NASDAQ), TRACON PHARMACEUTICALS INC (NASDAQ), IMMURON LIMITED (ASX), ALTERITY THERAPEUTICS LIMITED SPON ADS EA REPR 60 ORD SHS (NASDAQ), VICAL INC (NASDAQ), BIONOMICS LTD (ASX), REGENEUS LTD (ASX), NEUROSCIENTIFIC BIOPHARMA LTD (ASX), NANOVIRICIDES INC (NYSE American), ANTEO DIAGNOSTICS LIMITED (ASX), ONCONOVA THERAPEUTICS INC (NASDAQ), CELLMID LIMITED (ASX), DARE BIOSCIENCE INC (NASDAQ), NOVELION THERAPEUTICS INC (NASDAQ), IMMURON LIMITED SPON ADR EACH REPR 40 ORD SHS (NASDAQ), CONTANGO ASSET MANAGEMENT LIMITED (ASX), ACHIEVE LIFE SCIENCE INC (NASDAQ), GENETIC TECHNOLOGIES (ASX), ATYR PHARMA INC (NASDAQ), PRESCIENT THERAPEUTICS LIMITED (ASX), VAXART INC (NASDAQ), ANATARA LIFESCIENCES LTD (ASX), GENETIC TECHNOLOGIES SPON ADR EA REPR 150 ORD(POST SPLIT) (NASDAQ), MOTIF BIO PLC ADR EACH REPR 20 SHS SPON (NASDAQ), ENDRA LIFE SCIENCES INC (NASDAQ), TROVAGENE INC (NASDAQ), DIFFUSION PHARMACEUTICALS INC (NASDAQ), Suntar Eco-City^ (SGX), HOLISTA COLLTECH LIMITED (ASX), BIOXYNE LIMITED (ASX), CAN FITE BIOPHARMA LTD SPON ADS EA REP 30 ORD SHS(POST REV SPL (NYSE American), ARCA BIOPHARMA INC (NASDAQ), CONATUS PHARMACEUTICALS INC (NASDAQ), XTL BIOPHARMACEUTICALS LTD SPON ADR EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), PHIO PHARMACEUTICALS CORP (NASDAQ), BENITEC BIOPHARMA LTD (ASX), CYCLACEL PHARMA IN (NASDAQ), LIVING CELL TECHNOLOGIES (ASX), BENITEC BIOPHARMA LTD SPON ADR EA REPR 20 ORD (NASDAQ), QT Vascular (SGX), PROTEON THERAPEUTICS INC (NASDAQ), THERAPIX BIOSCIENCES LTD SPON ADR EACH REP 40 ORD (POST SPLIT) (NASDAQ), ACTINOGEN MEDICAL LTD (ASX), ADVAXIS INC (NASDAQ), MGRC (Bursa), MEGASUN (Bursa), AURIS MEDICAL HOLDING LTD (NASDAQ), INVIVO THERAPEUTICS HOLDING CORP (NASDAQ), OPGEN INC (NASDAQ), CCP TECHNOLOGIES LTD (ASX), TBG DIAGNOSTICS LTD (ASX), NEURALSTEM INC (NASDAQ), CYTORI THERAPEUTICS INC (NASDAQ), AVECHO BIOTECHNOLOGY LTD (ASX), AMPLIA THERAPEUTICS LTD (ASX), NOVITA HEALTHCARE LTD (ASX), MEDIBIO LIMITED (ASX), NANOLLOSE LTD (ASX), XENETIC BIOSCIENCES INC (NASDAQ), CELLECT BIOTECHNOLOGY LTD SPON ADR EACH REP 20 ORD SHS (NASDAQ), TRILLIUM THERAPEUTICS INC (NASDAQ), FACTOR THERAPEUTICS LIMITED (ASX), BPH ENERGY LIMITED (ASX), SINOVAC BIOTECH (NASDAQ), ALCHEMIA LIMITED (ASX), GENERA BIOSYSTEMS LIMITED (ASX)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days ---
10 Days ---
20 Days ---
Medium Term Return 3 Months ---
6 Months ---
1 Year ---
Long Term Return 2 Years -+556.000
+125.23 %
3 Years -+334.000
+50.15 %
5 Years -+569.240
+132.15 %
Annualised Return Annualised --
+18.35 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 1,000.000 - 1,000.000 Change From 1 Year Low - % Change From 1 Year Low (%) -
Change From 1 Year High - % Change From 1 Year High (%) -
2 Years Range 444.000 - 1,000.000 Change From 2 Years Low +556.000 % Change From 2 Years Low (%) +125.23
Change From 2 Years High - % Change From 2 Years High (%) -
5 Years Range 430.760 - 1,050.000 Change From 5 Years Low +569.240 % Change From 5 Years Low (%) +132.15
Change From 5 Years High -50.000 % Change From 5 Years High (%) -4.76
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture and marketing of human therapeutics. Its products include the following brands: Aranesp, BLINCYTO, Corlanor, ENBREL, EPOGEN, IMLYGIC, KYPROLIS, Neulasta, NEUPOGEN, Nplate, Parsabiv, Prolia, Repatha, Sensipar, Vectibix, and XGEVA. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.

Historical Price Data

Date Open High Low Close Volume VWAP
23 Jul 2019 1000.000 1000.000 1000.000 1000.000 - -
22 Jul 2019 1000.000 1000.000 1000.000 1000.000 - -
19 Jul 2019 1000.000 1000.000 1000.000 1000.000 - -
18 Jul 2019 1000.000 1000.000 1000.000 1000.000 - -
17 Jul 2019 1000.000 1000.000 1000.000 1000.000 - -
16 Jul 2019 1000.000 1000.000 1000.000 1000.000 - -
15 Jul 2019 1000.000 1000.000 1000.000 1000.000 - -
12 Jul 2019 1000.000 1000.000 1000.000 1000.000 - -
11 Jul 2019 1000.000 1000.000 1000.000 1000.000 - -
10 Jul 2019 1000.000 1000.000 1000.000 1000.000 - -
09 Jul 2019 1000.000 1000.000 1000.000 1000.000 - -
08 Jul 2019 1000.000 1000.000 1000.000 1000.000 - -
05 Jul 2019 1000.000 1000.000 1000.000 1000.000 - -
04 Jul 2019 1000.000 1000.000 1000.000 1000.000 - -
03 Jul 2019 1000.000 1000.000 1000.000 1000.000 - -
02 Jul 2019 1000.000 1000.000 1000.000 1000.000 - -
28 Jun 2019 1000.000 1000.000 1000.000 1000.000 - -
27 Jun 2019 1000.000 1000.000 1000.000 1000.000 - -
26 Jun 2019 1000.000 1000.000 1000.000 1000.000 - -
25 Jun 2019 1000.000 1000.000 1000.000 1000.000 - -
24 Jun 2019 1000.000 1000.000 1000.000 1000.000 - -
21 Jun 2019 1000.000 1000.000 1000.000 1000.000 - -
Summary
Current 2 Weeks
(10 Jul 2019 to 23 Jul 2019)
1000.000 1000.000 1000.000 1000.000 - -
Previous 2 Weeks
(25 Jun 2019 to 09 Jul 2019)
1000.000 1000.000 1000.000 1000.000 - -
4 Weeks from
(27 May 2019 to 24 Jun 2019)
1000.000 1000.000 1000.000 1000.000 - -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.